ALXO - Alx Oncology Holdings Inc
2.15
0.110 5.116%
Share volume: 334,648
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.04
0.11
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-07-2024 | 03-06-2025 | 05-08-2025 | 11-07-2025 | |
| Assets | |||||||
| Total Assets | 212.650 M | 214.618 M | 185.715 M | 147.775 M | 120.900 M | 82.723 M | |
| Current Assets | 167.864 M | 168.712 M | 155.895 M | 134.352 M | 102.532 M | 66.516 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 143.396 M | 141.189 M | 132.472 M | 110.190 M | 77.217 M | 37.184 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 14.041 M | 15.534 M | 16.102 M | 17.567 M | 20.614 M | 23.442 M | |
| Total Non-current Assets | 27.049 M | 29.475 M | 14.036 M | 3.524 M | 9.161 M | 5.838 M | |
| Property Plant Equipment | 3.441 M | 3.316 M | 3.112 M | 2.905 M | 2.703 M | 1.351 M | |
| Other Assets | 41.345 M | 42.590 M | 26.708 M | 10.518 M | 15.665 M | 14.856 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 212.650 M | 214.618 M | 185.715 M | 147.775 M | 120.900 M | 82.723 M | |
| Total liabilities | 48.455 M | 55.301 M | 48.908 M | 34.157 M | 32.605 M | 37.923 M | |
| Total current liabilities | 32.228 M | 38.449 M | 32.340 M | 18.500 M | 18.742 M | 27.722 M | |
| Accounts Payable | 6.227 M | 8.146 M | 7.891 M | 4.497 M | 3.937 M | 6.583 M | |
| Other liabilities | 6.524 M | 7.083 M | 6.733 M | 6.188 M | 5.631 M | 4.437 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 9.703 M | 9.769 M | 9.835 M | 9.469 M | 8.232 M | 5.764 M | |
| Other liabilities | 6.524 M | 7.083 M | 6.733 M | 6.188 M | 5.631 M | 4.437 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 164.195 M | 159.317 M | 136.807 M | 113.618 M | 88.295 M | 44.800 M | |
| Common stock | 686.020 M | 720.642 M | 728.203 M | 734.465 M | 740.053 M | 744.726 M | |
| Retained earnings | -521.853 M | -561.252 M | -591.959 M | -621.122 M | -651.876 M | -699.969 M |